Regulatory

Latest News

FDA Approves Akebia’s Vafseo for Anemia in Adults with Chronic Kidney Disease on Dialysis
FDA Approves Akebia’s Vafseo for Anemia in Adults with Chronic Kidney Disease on Dialysis

March 28th 2024

Approval of Vafsen (vadadustat) based on promising results from the INNO2VATE program and additional safety data from use in Japan in adults with chronic kidney disease.

FDA Approves Evolut TAVR System, Medtronic’s Treatment for Symptomatic Severe Aortic Stenosis
FDA Approves Evolut TAVR System, Medtronic’s Treatment for Symptomatic Severe Aortic Stenosis

March 28th 2024

FDA Approves Roche’s Cobas Malaria Test, Designed to Screen for Malaria in Potential Blood Donors
FDA Approves Roche’s Cobas Malaria Test, Designed to Screen for Malaria in Potential Blood Donors

March 27th 2024

FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension

March 27th 2024

Meg Alexander
Stakeholder Capitalism: Q&A with Meg Alexander, Chief Strategy Officer at Ovid Therapeutics (Part 2)

March 27th 2024

Video Interviews

More News